Wedbush Securities Inc’s Eli Lilly & Co Position
Does Wedbush Securities Inc own Eli Lilly & Co (LLY)? Yes — 18.4K shares worth $17M (+0.49% of its 13F portfolio) as of Q1 2026, up from 18.1K shares the prior filed quarter.
Position Value
$17M
Q1 2026
Shares
18.4K
% of Portfolio
+0.49%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 18.4K | $17M | +0.49% |
| Q4 2025 | 18.1K | $19M | +0.57% |
| Q3 2025 | 16.4K | $13M | +0.41% |
| Q2 2025 | 15.9K | $12M | +0.43% |
| Q1 2025 | 17.5K | $14M | +0.53% |
| Q4 2024 | 18.2K | $14M | +0.50% |
| Q3 2024 | 20.6K | $18M | +0.68% |
| Q2 2024 | 24.5K | $22M | +0.79% |
| Q1 2024 | 23.7K | $18M | +0.69% |
| Q4 2023 | 20.7K | $12M | +0.54% |
| Q3 2023 | 18.8K | $10M | +0.50% |
| Q2 2023 | 16.9K | $8M | +0.38% |
| Q1 2023 | 14.3K | $5M | +0.25% |
| Q4 2022 | 14.9K | $5M | +0.30% |
| Q3 2022 | 13.5K | $4M | +0.25% |
| Q2 2022 | 12.4K | $4M | +0.22% |
| Q1 2022 | 11.6K | $3M | +0.15% |
| Q4 2021 | 11.2K | $3M | +0.13% |
| Q3 2021 | 5.3K | $1M | +0.06% |
| Q2 2021 | 5.3K | $1M | +0.06% |
| Q1 2021 | 6.0K | $1M | +0.06% |
| Q4 2020 | 4.5K | $763,000 | +0.07% |
| Q3 2020 | 4.5K | $659,000 | +0.06% |
| Q2 2020 | 4.7K | $766,000 | +0.07% |
| Q1 2020 | 4.8K | $665,000 | +0.08% |
| Q4 2019 | 5.9K | $779,000 | +0.07% |
| Q3 2019 | 6.0K | $671,000 | +0.07% |
| Q2 2019 | 5.4K | $599,000 | +0.06% |
| Q1 2019 | 5.9K | $761,000 | +0.08% |
| Q4 2018 | 5.9K | $687,000 | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wedbush Securities Inc’s full portfolio or all institutional holders of LLY.